Locally advanced head and neck squamous cell cancer: treatment choice based on risk factors and optimizing drug prescription.
about
Anticancer Activity of Apaziquone in Oral Cancer Cells and Xenograft Model: Implications for Oral Cancer TherapyAnticancer activity of pyrithione zinc in oral cancer cells identified in small molecule screens and xenograft model: Implications for oral cancer therapy.Dynamic contrast-enhanced MRI evaluates the early response of human head and neck tumor xenografts following anti-EMMPRIN therapy with cisplatin or irradiation.De-escalation of radiation dose for human papillomavirus-positive oropharyngeal head and neck squamous cell carcinoma: A case report and preclinical and clinical literature review.Submental island flap reconstruction reduces cost in oral cancer reconstruction compared to radial forearm free flap reconstruction: a case series and cost analysisER maleate is a novel anticancer agent in oral cancer: implications for cancer therapy.Pigmented Basal cell carcinoma: a clinical variant, report of two cases.Maintenance of head and neck tumor on-chip: gateway to personalized treatment?Rapamycin enhances the anti-angiogenesis and anti-proliferation ability of YM155 in oral squamous cell carcinoma.Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab.Racial differences in head and neck squamous cell carcinomas among non-Hispanic black and white males identified through the National Cancer Database (1998-2012).Signal transduction growth factors: the effective governance of transcription and cellular adhesion in cancer invasion.On the Road to Immunotherapy-Prospects for Treating Head and Neck Cancers With Checkpoint Inhibitor AntibodiesInsonation of Systemically Delivered Cisplatin-Loaded Microbubbles Significantly Attenuates Nephrotoxicity of Chemotherapy in Experimental Models of Head and Neck Cancer
P2860
Q28546757-E0ADC689-053D-41CA-883B-DF0592922087Q35675984-96231908-E2E3-4979-AC80-1554C6979F0EQ35984544-13AF6CE9-C6B4-45F0-85E6-70ADA9E30BE2Q36502676-BDD4CA0A-545E-4CA3-A9C7-693E51A03D9EQ36549679-738A6F97-EE46-49C6-8AA8-D9D41F7BD26CQ37086229-66E610BA-7A47-42CB-9A64-51D7DE55F4ACQ37573147-0F4592BA-205F-4CAA-B2E1-06D54ADC45C2Q38663741-0F58D551-CFFD-478C-AEEE-DF55837FF259Q38700218-D090D0F3-95FD-40E7-AA89-52B4DF19D27EQ38736498-43E18068-0933-45CD-BB8E-453CE1276964Q38859472-DE3A5E53-AFA8-4A83-938A-86B4FFA1D7A8Q39246449-410E145B-EEEB-4D98-BFF2-E01EB0DABE32Q57492388-CA41BE7B-4213-440F-969F-741828D061F9Q58762549-41CF47AC-4A0C-4C56-83DC-E264889AAF31
P2860
Locally advanced head and neck squamous cell cancer: treatment choice based on risk factors and optimizing drug prescription.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Locally advanced head and neck ...... optimizing drug prescription.
@en
Locally advanced head and neck ...... optimizing drug prescription.
@nl
type
label
Locally advanced head and neck ...... optimizing drug prescription.
@en
Locally advanced head and neck ...... optimizing drug prescription.
@nl
prefLabel
Locally advanced head and neck ...... optimizing drug prescription.
@en
Locally advanced head and neck ...... optimizing drug prescription.
@nl
P2860
P356
P1433
P1476
Locally advanced head and neck ...... optimizing drug prescription.
@en
P2860
P304
P356
10.1093/ANNONC/MDS322
P478
23 Suppl 10
P577
2012-09-01T00:00:00Z